Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14274 | 714 | 25.1 | 51% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2356 | 3923 | I EM NEURODEGENERAT BRAIN//BERAPROST SODIUM//IBUDILAST |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MED BIOCHEM KURAMOTO CHO | Address | 3 | 100% | 0% | 3 |
2 | 4 ACETOXY 2 4 METHYLPHENYLBENZOTHIAZOLE | Author keyword | 2 | 67% | 0% | 2 |
3 | PHARMACEUT S KITA KU | Address | 2 | 67% | 0% | 2 |
4 | TEBUFELONE | Author keyword | 2 | 67% | 0% | 2 |
5 | 13 14 DIHYDRO PROSTAGLANDIN E1 | Author keyword | 1 | 50% | 0% | 2 |
6 | IMMUNOADSORPTION COLUMN | Author keyword | 1 | 100% | 0% | 2 |
7 | MED MED MED CLIN PHARMACOL | Address | 1 | 100% | 0% | 2 |
8 | NEONATAL HYPOXEMIC RESPIRATORY FAILURE | Author keyword | 1 | 50% | 0% | 2 |
9 | PGE M | Author keyword | 1 | 50% | 0% | 2 |
10 | PGF M | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 2 3 DINOR THROMBOXANE B2 | 41 | 100% | 2% | 15 |
2 | 11 DEHYDRO TXB2 | 13 | 80% | 1% | 8 |
3 | 11 DEHYDROTHROMBOXANE B2 | 12 | 48% | 3% | 19 |
4 | MONITORING THROMBOXANE PRODUCTION | 11 | 78% | 1% | 7 |
5 | THROMBOXANE B2 | 6 | 27% | 3% | 19 |
6 | 2 3 DINOR 6 KETO PGF1 ALPHA | 6 | 100% | 1% | 4 |
7 | 11 ALPHA HYDROXY 9 15 DIOXO 2 3 4 5 20 PENTANOR 19 CARBOXYPROSTANOIC ACID | 3 | 60% | 0% | 3 |
8 | QUANTITATIVE INDEX | 2 | 67% | 0% | 2 |
9 | THROMBOXANE METABOLITES | 1 | 50% | 0% | 2 |
10 | HUMAN CIRCULATION | 1 | 11% | 1% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Analysis of eicosanoids by LC-MS/MS and GC-MS/MS: A historical retrospect and a discussion | 2014 | 8 | 56 | 25% |
ELECTRON-CAPTURE NEGATIVE-ION CHEMICAL IONIZATION MASS-SPECTROMETRY OF LIPID MEDIATORS | 1990 | 36 | 33 | 58% |
Gas Chromatographic Determination of Prostaglandins | 2002 | 14 | 70 | 69% |
Application of gas chromatography mass spectrometry and gas chromatography tandem mass spectrometry to assess in vivo synthesis of prostaglandins, thromboxane, leukotrienes, isoprostanes and related compounds in humans | 1998 | 88 | 236 | 36% |
MEASUREMENT OF THROMBOXANE METABOLITES BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY | 1990 | 9 | 17 | 82% |
MEASUREMENTS OF THE INVIVO SYNTHESIS OF THROMBOXANE AND PROSTACYCLIN IN HUMANS | 1988 | 18 | 13 | 85% |
Affinity chromatography as a method for sample preparation in gas chromatography/mass spectrometry | 2001 | 18 | 86 | 21% |
EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON THE INVIVO SYNTHESIS OF THROMBOXANE AND PROSTACYCLIN IN HUMANS | 1991 | 6 | 11 | 64% |
Mass Spectrometry-based Quantitative Analysis and Biomarker Discovery | 2011 | 3 | 19 | 32% |
APPLICATIONS OF ISOTOPE-DILUTION MASS-SPECTROMETRY IN CLINICAL-CHEMISTRY, PHARMACOKINETICS, AND TOXICOLOGY | 1992 | 62 | 513 | 11% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED BIOCHEM KURAMOTO CHO | 3 | 100% | 0.4% | 3 |
2 | PHARMACEUT S KITA KU | 2 | 67% | 0.3% | 2 |
3 | MED MED MED CLIN PHARMACOL | 1 | 100% | 0.3% | 2 |
4 | MED PHARMACOL LARGO F VITO 1 | 1 | 27% | 0.4% | 3 |
5 | PHARMACEUT GRP S KITA KU | 1 | 33% | 0.3% | 2 |
6 | 110 OUEST AVE PINS | 1 | 50% | 0.1% | 1 |
7 | MALATTIE EMORRAG TROMBOT | 1 | 50% | 0.1% | 1 |
8 | MED PATHOPHYSIOL FUKUSHIMA KU | 1 | 50% | 0.1% | 1 |
9 | ST GORANS CHILDRENS HOSP CLIN NEUROSCI | 1 | 50% | 0.1% | 1 |
10 | CORP PLANNING OFF CHIYODA KU | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000128375 | PRACTICE POINTS//RENAL PROSTANOIDS//PAH CLEARANCE |
2 | 0.0000110326 | PHARMACOL RE6640//SPP301//AVOSENTAN |
3 | 0.0000109950 | PROSTACYCLIN STIMULATING FACTOR//CANINE PLATELET//CELLULAR METABOLITES |
4 | 0.0000098663 | ISOPROSTANES//ISOPROSTANE//NEUROPROSTANES |
5 | 0.0000095422 | ILOPROST//WESTERN INFIRM SURG//TAPROSTENE |
6 | 0.0000094671 | PHARMACEUT SCI 51 OHE HONMACHI//LONG CHAIN FREE FATTY ACIDS//FLUORESCENCE DERIVATIZATION REAGENT |
7 | 0.0000094337 | 9 ALLYLPURINES//ANTIPLATELET COMPOUNDS//HAMILTON GEN HOSP CLIN UNIT |
8 | 0.0000093630 | PLASMA RECALCIFICATION//TAIL BLEEDING TIME//RAT PLATELET |
9 | 0.0000086449 | CARBACYCLIN//CARBACYCLINS//SM 10906 |
10 | 0.0000082620 | N ACETYL 4 AMINOPHENOL//FOETAL TESTIS//PROSTAGLANDIN E SERIES |